WEALTHFRONT Corp cut its stake in shares of Danaher Co. (NYSE:DHR) by 2.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 22,294 shares of the conglomerate’s stock after selling 586 shares during the quarter. WEALTHFRONT Corp’s holdings in Danaher were worth $2,422,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently made changes to their positions in the company. Fort L.P. bought a new stake in Danaher during the second quarter valued at approximately $119,000. Braun Bostich & Associates Inc. lifted its position in Danaher by 506.4% during the second quarter. Braun Bostich & Associates Inc. now owns 1,225 shares of the conglomerate’s stock valued at $121,000 after purchasing an additional 1,023 shares during the last quarter. Reilly Financial Advisors LLC lifted its position in Danaher by 62.6% during the third quarter. Reilly Financial Advisors LLC now owns 1,301 shares of the conglomerate’s stock valued at $141,000 after purchasing an additional 501 shares during the last quarter. Sun Life Financial INC lifted its position in Danaher by 508.4% during the second quarter. Sun Life Financial INC now owns 1,667 shares of the conglomerate’s stock valued at $164,000 after purchasing an additional 1,393 shares during the last quarter. Finally, NEXT Financial Group Inc bought a new stake in Danaher during the third quarter valued at approximately $166,000. Institutional investors and hedge funds own 77.13% of the company’s stock.

DHR stock opened at $105.11 on Thursday. The company has a market cap of $74.51 billion, a price-to-earnings ratio of 26.17, a price-to-earnings-growth ratio of 2.05 and a beta of 1.06. Danaher Co. has a one year low of $91.84 and a one year high of $110.86. The company has a current ratio of 1.53, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Thursday, October 18th. The conglomerate reported $1.10 EPS for the quarter, topping the consensus estimate of $1.07 by $0.03. The firm had revenue of $4.85 billion for the quarter, compared to the consensus estimate of $4.80 billion. Danaher had a net margin of 14.07% and a return on equity of 11.59%. The business’s revenue was up 7.2% compared to the same quarter last year. During the same period last year, the firm posted $1.00 earnings per share. On average, analysts anticipate that Danaher Co. will post 4.51 EPS for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, January 25th. Investors of record on Friday, December 28th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a dividend yield of 0.61%. The ex-dividend date is Thursday, December 27th. Danaher’s payout ratio is 15.88%.

In related news, Director Donald J. Ehrlich sold 10,578 shares of Danaher stock in a transaction on Tuesday, October 23rd. The shares were sold at an average price of $95.77, for a total value of $1,013,055.06. Following the transaction, the director now directly owns 105,491 shares of the company’s stock, valued at $10,102,873.07. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP William K. Daniel sold 29,784 shares of Danaher stock in a transaction on Thursday, October 25th. The stock was sold at an average price of $98.04, for a total transaction of $2,920,023.36. Following the completion of the transaction, the executive vice president now directly owns 141,892 shares in the company, valued at $13,911,091.68. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 150,007 shares of company stock worth $15,202,163. 11.90% of the stock is owned by insiders.

Several research firms have commented on DHR. Zacks Investment Research raised shares of Danaher from a “hold” rating to a “buy” rating and set a $119.00 price target on the stock in a research note on Wednesday, September 19th. Morgan Stanley lifted their price target on shares of Danaher from $122.00 to $126.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 10th. Finally, Robert W. Baird decreased their price target on shares of Danaher from $116.00 to $114.00 and set an “outperform” rating on the stock in a research note on Friday, October 19th. One research analyst has rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $112.14.

WARNING: This story was first posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this story on another site, it was illegally copied and reposted in violation of U.S. and international copyright laws. The correct version of this story can be viewed at https://www.thecerbatgem.com/2018/12/06/danaher-co-dhr-shares-sold-by-wealthfront-corp.html.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides laser scanning, compound, surgical, and other stereo microscopes. This segment also offers filtration, separation, and purification technologies to the biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial sectors.

Featured Article: How is an ETF different from a mutual fund?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.